Medlive Technology Insider Lowered Holding By 58% During Last Year

Simply Wall St ·  09/28/2023 06:32

Viewing insider transactions for Medlive Technology Co., Ltd.'s (HKG:2192 ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in relation to shares purchased.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for Medlive Technology

The Last 12 Months Of Insider Transactions At Medlive Technology

Over the last year, we can see that the biggest insider sale was by the VP, Deputy Head of Medical Information Science Research Unit & Executive Director, Lijun Tian, for HK$2.1m worth of shares, at about HK$14.13 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is HK$8.06. So it is hard to draw any strong conclusion from it. The only individual insider seller over the last year was Lijun Tian.

Lijun Tian ditched 200.00k shares over the year. The average price per share was CN¥13.60. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

SEHK:2192 Insider Trading Volume September 27th 2023

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of Medlive Technology

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.1% of Medlive Technology shares, worth about HK$62m, according to our data. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Do The Medlive Technology Insider Transactions Indicate?

The fact that there have been no Medlive Technology insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by Medlive Technology insiders. But it's good to see that insiders own shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Medlive Technology. You'd be interested to know, that we found 1 warning sign for Medlive Technology and we suggest you have a look.

But note: Medlive Technology may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment